Stock A100120 VIEWORKS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Vieworks Co., Ltd.

Equities

A100120

KR7100120005

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
28,250 KRW +1.62% Intraday chart for Vieworks Co., Ltd. -1.22% +4.63%
2023 Vieworks Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 Vieworks' Vivix X-Ray Flat Panel Detector Full Line-Up to Be Showcased At Ecr 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The company's attractive earnings multiples are brought to light by a P/E ratio at 10.4 for the current year.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+4.63% 189M -
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-11.17% 13.76B -
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-14.97% 2.39B -
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-45.53% 2.49B
C-
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-18.85% 1.34B - -
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B - -
GUERBET Stock Guerbet
+85.90% 495M
B+
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+24.45% 272M
C
DRTECH CORPORATION Stock DRTECH Corporation
-11.03% 204M - -
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 178M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A100120 Stock
  4. Ratings Vieworks Co., Ltd.